Bone Biologics Corporation (NASDAQ:BBLG) does about 312.25K shares in volume on a normal day but saw 212803 shares change hands in Friday trading. The company now has a market cap of 5.47M USD. Its current market price is $0.35, marking a decrease of -2.78% compared to the previous close of $0.36. The 52 week high reached by this stock is $4.07 whilst the lowest price level in 52 weeks is $0.18. The script in recent trading has seen the stock touch a high of $0.36 and a low of $0.3303.
Bone Biologics Corporation (BBLG) has a 20-day trading average at $0.3255 and the current price is -91.40% off the 52-week high compared with 96.96% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2802 and its 200-day simple moving average is $0.8956. If we look at the stock’s price movements over the week, volatility stands at 12.70%, which increases to 13.68% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 57.16 to suggest the stock is neutral.
1 analysts observing the Bone Biologics Corporation (BBLG) stock have set the 12-month price targets for the company’s shares at between $2.25 and $2.25. The consensus objective for the share price is $4.88, suggesting that the stock has a potential upside of 92.83% over the period. The median price target is 84.44% away from the current levels at $2.25.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The current price level is 8.44%, 25.53%, and -61.29% away from its SMA20, SMA50, and SMA200 respectively, with the BBLG price moving below the 50-day SMA on February 17. Bone Biologics Corporation (BBLG) stock is up 5.01% over the week and 19.62% over the past month. Its price is 66.91% year-to-date and -83.64% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of -$0.12 above consensus estimates by $0.03. The company’s next earnings report is expected on 05/31/2023, with forecasts estimating quarterly EPS at -$0.22 and -$0.47 for whole year. BBLG’s earnings per share are forecast to shrink by -34.30% this year and -40.40% over next year.
Its 12-month price target is $2.25. To reach the target analysts have set, the stock logically needs to grow 92.83 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $2.25, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $2.25.
Outstanding shares total 10.35M with insiders holding 47.09% of the shares and institutional holders owning 13.33% of the company’s common stock. The company has a return on equity of -45.20%. Price to book ratio is 0.81.
